Nativi-Nicolau, Jose

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

Kittleson, M. M., Maurer, M. S., Ambardekar, A. V., Bullock-Palmer, R. P., Chang, P. P., Eisen, H. J., Nair, A. P., Nativi-Nicolau, J., Ruberg, F. L., & On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology (2020) · Circulation

Amyloidosis: Diagnosis, Treatment, OutcomesCardiac tumors and thrombi

Cited by 756

Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study

Stehlik, J., Schmalfuss, C., Bozkurt, B., Nativi-Nicolau, J., Wohlfahrt, P., Wegerich, S., Rose, K., Ray, R., Schofield, R., Deswal, A., et al. (2020) · Circulation Heart Failure

Heart Failure Treatment and ManagementNon-Invasive Vital Sign Monitoring

Cited by 333

Estimating the Health Benefits of Timely Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy

Rozenbaum, M. H., Large, S., Bhambri, R., Stewart, M., Young, R., Doornewaard, A. V., Dasgupta, N., Masri, A., & Nativi-Nicolau, J. (2021) · Journal of Comparative Effectiveness Research

Amyloidosis: Diagnosis, Treatment, OutcomesHealth Systems, Economic Evaluations, Quality of Life

Cited by 19